Odevixibat – March 2025

• Brand names:
  • Bylvay®
• Pharmaceutical Company:
  • IPSEN PTY LTD
• Condition/Indication: Progressive familial intrahepatic cholestasis (PFIC)
• Meeting Date: March 2025
• Public Summary Document (PSD) March 2025 July 2025 PBAC Meetings - (PDF 1.4MB)
• Public Summary Document (PSD) March 2025 July 2025 PBAC Meetings - (Word 386KB)

Related Public Summary Documents

• Odevixibat – July 2025